Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 03/27/2025
Short Title (70 char) BlendHouse Portland LLC. Portland, OR. EIR issued 03/27/2025
FEI Number 3013670080
Firm Name BlendHouse Portland LLC
Record Type EIR
State OR
Establishment Type Manufacturer
Similar Posts
Face Rock Creamery LLC Recalls 6oz. Vampire Slayer Garlic Cheddar Because of Possible Health Risk
November 14, 2025, Face Rock Creamery LLC of Bandon, OR is voluntarily recalling 16/6oz. units of Vampire Slayer Garlic Cheddar with a use-by date of 11/04/26 because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infectioHillside Orchard Farms Recalls Various Fruit Breads & Fritters Due to Undeclared Egg
Tiger GA – July 28, 2025 – Hillside Orchard Farms is recalling various flavors of their 23oz Fruit Breads & 7.5 oz Fritters due to an undeclared allergen of Egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume theCharles H. Harper, M.D. Norfolk, NE. EIR issued 11/13/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/13/2020
Short Title (70 char) Charles H. Harper, M.D. Norfolk, NE. EIR issued 11/13/2020
FEI Number 3015685119
Firm Name Charles H. Harper, M.D.
Record Type EIR
State NE
Establishment Type Clinical InvestigatAbsolutely Natural – 715690 – 12/30/2025
CGMP/Finished Pharmaceuticals/AdulteratedKVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a Precautionary Measure Due to a Single Foreign Tablet Found During the Line Clearance After the Batch was Packaged
Newtown, Pennsylvania, KVK-Tech, Inc. is voluntarily recalling one lot (Batch Number: 17853A; “the batch”) of Betaxolol Tablets, USP 10 mg, White, Round, film coated biconvex tablets, debossed “K” above bisect “13” on one side and plain on the other side” to the consumer level. The batch was distribCDER Center for Clinical Trial Innovation (C3TI)
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaboration